SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

YIELD10 Bioscience, Inc. – ‘10-Q’ for 9/30/22 – ‘JSON’

On:  Monday, 11/14/22, at 4:14pm ET   ·   For:  9/30/22   ·   Accession #:  1121702-22-49   ·   File #:  1-33133

Previous ‘10-Q’:  ‘10-Q’ on 8/10/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/12/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/14/22  YIELD10 Bioscience, Inc.          10-Q        9/30/22   60:4.8M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.02M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: R1          Cover                                               HTML     69K 
11: R2          Condensed Consolidated Statements of Operations     HTML     85K 
                Unaudited                                                        
12: R3          Condensed Consolidated Balance Sheets Unaudited     HTML    112K 
13: R4          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Loss Unaudited                                                   
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     89K 
                Unaudited                                                        
16: R7          Condensed Consolidated Statements of Stockholders'  HTML     81K 
                Equity                                                           
17: R8          Accounting Policies                                 HTML     51K 
18: R9          Nature of Business and Basis of Presentation        HTML     32K 
19: R10         Basic and Diluted Net Loss Per Share                HTML     28K 
20: R11         Investments                                         HTML     37K 
21: R12         Fair Value Measurements                             HTML     50K 
22: R13         Accrued Expenses                                    HTML     27K 
23: R14         Stock-Based Compensation                            HTML     37K 
24: R15         Leases                                              HTML     46K 
25: R16         Commitments and Contingencies                       HTML     27K 
26: R17         License Agreements                                  HTML     21K 
27: R18         Geographic Information                              HTML     42K 
28: R19         Capital Stock and Warrants                          HTML     42K 
29: R20         Accounting Policies (Policies)                      HTML     93K 
30: R21         Accounting Policies (Tables)                        HTML     37K 
31: R22         Basic and Diluted Net Loss Per Share (Tables)       HTML     26K 
32: R23         Investments (Tables)                                HTML     36K 
33: R24         Fair Value Measurements (Tables)                    HTML     47K 
34: R25         Accrued Expenses (Tables)                           HTML     26K 
35: R26         Stock-Based Compensation (Tables)                   HTML     35K 
36: R27         Leases (Tables)                                     HTML     44K 
37: R28         Geographic Information (Tables)                     HTML     39K 
38: R29         Capital Stock and Warrants (Tables)                 HTML     43K 
39: R30         ACCOUNTING POLICIES - Additional Information        HTML     35K 
                (Details)                                                        
40: R31         ACCOUNTING POLICIES - Schedule of Cash And          HTML     27K 
                Restricted Cash (Details)                                        
41: R32         Nature of Business and Basis of Presentation        HTML     20K 
                (Details)                                                        
42: R33         Basic and Diluted Net Loss Per Share (Details)      HTML     27K 
43: R34         Investments (Details)                               HTML     30K 
44: R35         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     45K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
45: R36         Accrued Expenses (Details)                          HTML     29K 
46: R37         Stock-Based Compensation (Details)                  HTML     82K 
47: R38         Stock-Based Compensation - RSU Activity (Details)   HTML     28K 
48: R39         LEASES - Narrative (Details)                        HTML     31K 
49: R40         LEASES - Maturity Analysis of Lease Liabilities     HTML     38K 
                (Details)                                                        
50: R41         LEASES - Quantitative Disclosure of Lease Costs     HTML     33K 
                (Details)                                                        
51: R42         Commitments and Contingencies (Details)             HTML     32K 
52: R43         Geographic Information (Details)                    HTML     31K 
53: R44         CAPITAL STOCK AND WARRANTS - Narrative (Details)    HTML     39K 
54: R45         CAPITAL STOCK AND WARRANTS - Schedule Of Warrants   HTML     34K 
                Issuance (Details)                                               
55: R46         CAPITAL STOCK AND WARRANTS - Schedule of Common     HTML     25K 
                Stock Reserved For Future Issuance (Details)                     
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- yten-20220930_htm                   XML   1.11M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 6: EX-101.CAL  XBRL Calculations -- yten-20220930_cal               XML    135K 
 7: EX-101.DEF  XBRL Definitions -- yten-20220930_def                XML    311K 
 8: EX-101.LAB  XBRL Labels -- yten-20220930_lab                     XML   1.05M 
 9: EX-101.PRE  XBRL Presentations -- yten-20220930_pre              XML    584K 
 5: EX-101.SCH  XBRL Schema -- yten-20220930                         XSD     96K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              296±   448K 
60: ZIP         XBRL Zipped Folder -- 0001121702-22-000049-xbrl      Zip    259K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "yten-20220930.htm":  {
        "axisCustom":  0,
        "axisStandard":  17,
        "contextCount":  135,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "yten-20220930_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "yten-20220930_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "yten-20220930.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "yten-20220930_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "yten-20220930_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "yten-20220930.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
                    "https://xbrl.sec.gov/country/2022/country-2022.xsd",
                    "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
                    ]
                }
            },
        "elementCount":  360,
        "entityCount":  1,
        "hidden":  {
            "http://xbrl.sec.gov/dei/2022":  5,
            "total":  5
            },
        "keyCustom":  21,
        "keyStandard":  211,
        "memberCustom":  11,
        "memberStandard":  22,
        "nsprefix":  "yten",
        "nsuri":  "http://www.yield10bio.com/20220930",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "0000001 - Document - Cover",
                "role":  "http://www.yield10bio.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE",
                "role":  "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARE",
                "shortName":  "BASIC AND DILUTED NET LOSS PER SHARE",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000011 - Disclosure - INVESTMENTS",
                "role":  "http://www.yield10bio.com/role/INVESTMENTS",
                "shortName":  "INVESTMENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000012 - Disclosure - FAIR VALUE MEASUREMENTS",
                "role":  "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTS",
                "shortName":  "FAIR VALUE MEASUREMENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000013 - Disclosure - ACCRUED EXPENSES",
                "role":  "http://www.yield10bio.com/role/ACCRUEDEXPENSES",
                "shortName":  "ACCRUED EXPENSES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000014 - Disclosure - STOCK-BASED COMPENSATION",
                "role":  "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATION",
                "shortName":  "STOCK-BASED COMPENSATION",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000015 - Disclosure - LEASES",
                "role":  "http://www.yield10bio.com/role/LEASES",
                "shortName":  "LEASES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000016 - Disclosure - COMMITMENTS AND CONTINGENCIES",
                "role":  "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIES",
                "shortName":  "COMMITMENTS AND CONTINGENCIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "yten:LicensingAgreementsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000017 - Disclosure - LICENSE AGREEMENTS",
                "role":  "http://www.yield10bio.com/role/LICENSEAGREEMENTS",
                "shortName":  "LICENSE AGREEMENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "yten:LicensingAgreementsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000018 - Disclosure - GEOGRAPHIC INFORMATION",
                "role":  "http://www.yield10bio.com/role/GEOGRAPHICINFORMATION",
                "shortName":  "GEOGRAPHIC INFORMATION",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000019 - Disclosure - CAPITAL STOCK AND WARRANTS",
                "role":  "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTS",
                "shortName":  "CAPITAL STOCK AND WARRANTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "yten:CostOfRevenueResearchAndDevelopmentExpenses",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000020 - Disclosure - ACCOUNTING POLICIES (Policies)",
                "role":  "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies",
                "shortName":  "ACCOUNTING POLICIES (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000021 - Disclosure - ACCOUNTING POLICIES (Tables)",
                "role":  "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESTables",
                "shortName":  "ACCOUNTING POLICIES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000022 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)",
                "role":  "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARETables",
                "shortName":  "BASIC AND DILUTED NET LOSS PER SHARE (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000023 - Disclosure - INVESTMENTS (Tables)",
                "role":  "http://www.yield10bio.com/role/INVESTMENTSTables",
                "shortName":  "INVESTMENTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
                "role":  "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSTables",
                "shortName":  "FAIR VALUE MEASUREMENTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000025 - Disclosure - ACCRUED EXPENSES (Tables)",
                "role":  "http://www.yield10bio.com/role/ACCRUEDEXPENSESTables",
                "shortName":  "ACCRUED EXPENSES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000026 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
                "role":  "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONTables",
                "shortName":  "STOCK-BASED COMPENSATION (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000027 - Disclosure - LEASES (Tables)",
                "role":  "http://www.yield10bio.com/role/LEASESTables",
                "shortName":  "LEASES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000028 - Disclosure - GEOGRAPHIC INFORMATION (Tables)",
                "role":  "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONTables",
                "shortName":  "GEOGRAPHIC INFORMATION (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000029 - Disclosure - CAPITAL STOCK AND WARRANTS (Tables)",
                "role":  "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSTables",
                "shortName":  "CAPITAL STOCK AND WARRANTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS UNAUDITED",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
                "shortName":  "CONDENSED CONSOLIDATED BALANCE SHEETS UNAUDITED",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:ShortTermInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RestrictedCashAndCashEquivalents",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000030 - Disclosure - ACCOUNTING POLICIES - Additional Information (Details)",
                "role":  "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails",
                "shortName":  "ACCOUNTING POLICIES - Additional Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:SegmentReportingPolicyPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000031 - Disclosure - ACCOUNTING POLICIES - Schedule of Cash And Restricted Cash (Details)",
                "role":  "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails",
                "shortName":  "ACCOUNTING POLICIES - Schedule of Cash And Restricted Cash (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashCashEquivalentsAndShortTermInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000032 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
                "role":  "http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
                "shortName":  "NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashCashEquivalentsAndShortTermInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000033 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)",
                "role":  "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
                "shortName":  "BASIC AND DILUTED NET LOSS PER SHARE (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i814986cb521646248f9fc45f4abed8cf_I20211231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000034 - Disclosure - INVESTMENTS (Details)",
                "role":  "http://www.yield10bio.com/role/INVESTMENTSDetails",
                "shortName":  "INVESTMENTS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i814986cb521646248f9fc45f4abed8cf_I20211231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i814986cb521646248f9fc45f4abed8cf_I20211231",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000035 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "role":  "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                "shortName":  "FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i30991a5bda6e4812bd1c6645524593ec_I20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:AssetsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeRelatedLiabilitiesCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000036 - Disclosure - ACCRUED EXPENSES (Details)",
                "role":  "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails",
                "shortName":  "ACCRUED EXPENSES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeRelatedLiabilitiesCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000037 - Disclosure - STOCK-BASED COMPENSATION (Details)",
                "role":  "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                "shortName":  "STOCK-BASED COMPENSATION (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i6d193826a5c343bea53efc73378adcd3_I20211231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000038 - Disclosure - STOCK-BASED COMPENSATION - RSU Activity (Details)",
                "role":  "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails",
                "shortName":  "STOCK-BASED COMPENSATION - RSU Activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i6d193826a5c343bea53efc73378adcd3_I20211231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AreaOfRealEstateProperty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "sqft",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000039 - Disclosure - LEASES - Narrative (Details)",
                "role":  "http://www.yield10bio.com/role/LEASESNarrativeDetails",
                "shortName":  "LEASES - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AreaOfRealEstateProperty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "sqft",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:PreferredStockParOrStatedValuePerShare",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PreferredStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
                "shortName":  "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:PreferredStockSharesIssued",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000040 - Disclosure - LEASES - Maturity Analysis of Lease Liabilities (Details)",
                "role":  "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails",
                "shortName":  "LEASES - Maturity Analysis of Lease Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000041 - Disclosure - LEASES - Quantitative Disclosure of Lease Costs (Details)",
                "role":  "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails",
                "shortName":  "LEASES - Quantitative Disclosure of Lease Costs (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic40a7f95d8864139bc825c075a4045aa_D20201101-20201130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "yten:CollaborativeArrangementTerm",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
                "role":  "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails",
                "shortName":  "COMMITMENTS AND CONTINGENCIES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic40a7f95d8864139bc825c075a4045aa_D20201101-20201130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "yten:CollaborativeArrangementTerm",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000043 - Disclosure - GEOGRAPHIC INFORMATION (Details)",
                "role":  "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails",
                "shortName":  "GEOGRAPHIC INFORMATION (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i8fd36b9fac6b47a0ab43fdaf37e9b0f3_D20220701-20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:PreferredStockSharesAuthorized",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000044 - Disclosure - CAPITAL STOCK AND WARRANTS - Narrative (Details)",
                "role":  "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                "shortName":  "CAPITAL STOCK AND WARRANTS - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ied311cf50bcf4cca8b533444c3e96ad3_D20220519-20220519",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "yten:ClassOfWarrantOrRightExpired",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000045 - Disclosure - CAPITAL STOCK AND WARRANTS - Schedule Of Warrants Issuance (Details)",
                "role":  "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails",
                "shortName":  "CAPITAL STOCK AND WARRANTS - Schedule Of Warrants Issuance (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockByClassTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000046 - Disclosure - CAPITAL STOCK AND WARRANTS - Schedule of Common Stock Reserved For Future Issuance (Details)",
                "role":  "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails",
                "shortName":  "CAPITAL STOCK AND WARRANTS - Schedule of Common Stock Reserved For Future Issuance (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfStockByClassTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ie7f39f21b1a740349051d15cf44c8420_I20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS UNAUDITED",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS UNAUDITED",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "ic9b09c112b864cf5b6d8723ccdbe82bb_D20220701-20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:DepreciationDepletionAndAmortization",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i8f56f26d006446df9f97161c0e9d6229_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
                "role":  "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i8f56f26d006446df9f97161c0e9d6229_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000008 - Disclosure - ACCOUNTING POLICIES",
                "role":  "http://www.yield10bio.com/role/ACCOUNTINGPOLICIES",
                "shortName":  "ACCOUNTING POLICIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "0000009 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION",
                "role":  "http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION",
                "shortName":  "NATURE OF BUSINESS AND BASIS OF PRESENTATION",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "yten-20220930.htm",
                    "contextRef":  "i94ba0edb52974aa0bc4a84c428f59d19_D20220101-20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  36,
        "tag":  {
            "country_CA":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CANADA",
                            "terseLabel":  "Canada"
                            }
                        }
                    },
                "localname":  "CA",
                "nsuri":  "http://xbrl.sec.gov/country/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "country_US":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "UNITED STATES",
                            "terseLabel":  "U.S."
                            }
                        }
                    },
                "localname":  "US",
                "nsuri":  "http://xbrl.sec.gov/country/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]",
                            "terseLabel":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r530"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report",
                            "terseLabel":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "All the names of the entities being reported upon in a document.  Any legal structure used to conduct activities or to hold assets.  Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts.  This item does not include business and geographical segments which are included in the geographical or business segments domains.",
                            "label":  "Entity [Domain]",
                            "terseLabel":  "Entity [Domain]"
                            }
                        }
                    },
                "localname":  "EntityDomain",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r540"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_LegalEntityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The set of legal entities associated with a report.",
                            "label":  "Legal Entity [Axis]",
                            "terseLabel":  "Legal Entity [Axis]"
                            }
                        }
                    },
                "localname":  "LegalEntityAxis",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r527"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r529"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "srt_MajorCustomersAxis":  {
                "auth_ref":  [
                    "r161",
                    "r264",
                    "r267",
                    "r497"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Axis]",
                            "terseLabel":  "Customer [Axis]"
                            }
                        }
                    },
                "localname":  "MajorCustomersAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_NameOfMajorCustomerDomain":  {
                "auth_ref":  [
                    "r161",
                    "r264",
                    "r267",
                    "r497"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Domain]",
                            "terseLabel":  "Customer [Domain]"
                            }
                        }
                    },
                "localname":  "NameOfMajorCustomerDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ProductOrServiceAxis":  {
                "auth_ref":  [
                    "r157",
                    "r206",
                    "r207",
                    "r264",
                    "r265",
                    "r458",
                    "r494",
                    "r495"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]",
                            "terseLabel":  "Product and Service [Axis]"
                            }
                        }
                    },
                "localname":  "ProductOrServiceAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ProductsAndServicesDomain":  {
                "auth_ref":  [
                    "r157",
                    "r206",
                    "r207",
                    "r264",
                    "r265",
                    "r458",
                    "r494",
                    "r495"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Domain]",
                            "terseLabel":  "Product and Service [Domain]"
                            }
                        }
                    },
                "localname":  "ProductsAndServicesDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis":  {
                "auth_ref":  [
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r526"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Name of Property [Axis]",
                            "terseLabel":  "Name of Property [Axis]"
                            }
                        }
                    },
                "localname":  "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain":  {
                "auth_ref":  [
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r526"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Name of Property [Domain]",
                            "terseLabel":  "Name of Property [Domain]"
                            }
                        }
                    },
                "localname":  "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_SegmentGeographicalDomain":  {
                "auth_ref":  [
                    "r158",
                    "r159",
                    "r264",
                    "r266",
                    "r496",
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Geographical [Domain]",
                            "terseLabel":  "Geographical [Domain]"
                            }
                        }
                    },
                "localname":  "SegmentGeographicalDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_StatementGeographicalAxis":  {
                "auth_ref":  [
                    "r158",
                    "r159",
                    "r264",
                    "r266",
                    "r496",
                    "r512",
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Geographical [Axis]",
                            "terseLabel":  "Geographical [Axis]"
                            }
                        }
                    },
                "localname":  "StatementGeographicalAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]",
                            "terseLabel":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r26"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
                            "label":  "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
                            "terseLabel":  "ACCRUED EXPENSES"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSES"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r25",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r163",
                    "r164"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued expenses",
                            "totalLabel":  "Total accrued expenses"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedProfessionalFeesCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Professional Fees, Current",
                            "terseLabel":  "Professional services"
                            }
                        }
                    },
                "localname":  "AccruedProfessionalFeesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "auth_ref":  [
                    "r19",
                    "r36",
                    "r37",
                    "r38",
                    "r483",
                    "r505",
                    "r509"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end.  Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.  Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                            "terseLabel":  "Accumulated other comprehensive loss"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "auth_ref":  [
                    "r35",
                    "r38",
                    "r46",
                    "r47",
                    "r48",
                    "r82",
                    "r83",
                    "r84",
                    "r357",
                    "r423",
                    "r500",
                    "r501"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
                            "label":  "AOCI Attributable to Parent [Member]",
                            "terseLabel":  "Accumulated Other Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdditionalPaidInCapitalCommonStock":  {
                "auth_ref":  [
                    "r17"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions.  Includes only common stock transactions (excludes preferred stock transactions).  May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
                            "label":  "Additional Paid in Capital, Common Stock",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r82",
                    "r83",
                    "r84",
                    "r320",
                    "r321",
                    "r322",
                    "r370"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional Paid-In Capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
                            "negatedTerseLabel":  "Taxes paid on employees' behalf related to vesting of stock awards"
                            }
                        }
                    },
                "localname":  "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "auth_ref":  [
                    "r278",
                    "r324",
                    "r325"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
                            "label":  "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
                            "terseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r107"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Antidilutive common stock excluded from the calculation of dilutive shares"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r107"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]",
                            "terseLabel":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
                            "terseLabel":  "Antidilutive securities"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r107"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
                            "label":  "Antidilutive Securities, Name [Domain]",
                            "terseLabel":  "Antidilutive Securities, Name [Domain]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AreaOfRealEstateProperty":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area of a real estate property.",
                            "label":  "Area of Real Estate Property",
                            "terseLabel":  "Leased area (in sq ft)"
                            }
                        }
                    },
                "localname":  "AreaOfRealEstateProperty",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "areaItemType"
                },
            "us-gaap_ArrangementsAndNonarrangementTransactionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
                            "terseLabel":  "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
                            }
                        }
                    },
                "localname":  "ArrangementsAndNonarrangementTransactionsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r12",
                    "r78",
                    "r137",
                    "r147",
                    "r153",
                    "r180",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r353",
                    "r358",
                    "r383",
                    "r424",
                    "r426",
                    "r465",
                    "r481"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r8",
                    "r24",
                    "r78",
                    "r180",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r353",
                    "r358",
                    "r383",
                    "r424",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current Assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsFairValueDisclosure":  {
                "auth_ref":  [
                    "r374"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Fair Value Disclosure",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "AssetsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":  {
                "auth_ref":  [
                    "r171"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/INVESTMENTSDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
                            "terseLabel":  "Unrealized Gain"
                            }
                        }
                    },
                "localname":  "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":  {
                "auth_ref":  [
                    "r172"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/INVESTMENTSDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
                            "negatedTerseLabel":  "Unrealized (Loss)"
                            }
                        }
                    },
                "localname":  "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis":  {
                "auth_ref":  [
                    "r169",
                    "r192"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/INVESTMENTSDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale, Amortized Cost",
                            "totalLabel":  "Accumulated Cost"
                            }
                        }
                    },
                "localname":  "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AvailableForSaleSecuritiesDebtSecurities":  {
                "auth_ref":  [
                    "r168",
                    "r170",
                    "r192",
                    "r469"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsFairValueDisclosure",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/INVESTMENTSDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale",
                            "terseLabel":  "Market Value",
                            "verboseLabel":  "Short-term investments"
                            }
                        }
                    },
                "localname":  "AvailableForSaleSecuritiesDebtSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r282",
                    "r283",
                    "r284",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r303",
                    "r304",
                    "r306",
                    "r307",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r314"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Accounting, Policy [Policy Text Block]",
                            "terseLabel":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock":  {
                "auth_ref":  [
                    "r6",
                    "r81",
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Business Description and Basis of Presentation [Text Block]",
                            "verboseLabel":  "NATURE OF BUSINESS AND BASIS OF PRESENTATION"
                            }
                        }
                    },
                "localname":  "BusinessDescriptionAndBasisOfPresentationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r7",
                    "r10",
                    "r70"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAxis":  {
                "auth_ref":  [
                    "r10"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of cash and cash equivalent balance.",
                            "label":  "Cash and Cash Equivalents [Axis]",
                            "terseLabel":  "Cash and Cash Equivalents [Axis]"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsFairValueDisclosure":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsFairValueDisclosure",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash and Cash Equivalents, Fair Value Disclosure",
                            "terseLabel":  "Cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy":  {
                "auth_ref":  [
                    "r71",
                    "r464"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
                            "label":  "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Cash, Cash Equivalents and Restricted Cash"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsAndShortTermInvestments":  {
                "auth_ref":  [
                    "r24"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash includes currency on hand as well as demand deposits with banks or financial institutions.  It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty.  Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates.  Generally, only investments with original maturities of three months or less qualify under that definition.  Original maturity means original maturity to the entity holding the investment.  For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents.  However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months.  Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
                            "label":  "Cash, Cash Equivalents, and Short-Term Investments",
                            "verboseLabel":  "Unrestricted cash and cash equivalents and short-term investments"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsAndShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r65",
                    "r70",
                    "r72"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash, cash equivalents and restricted cash at end of period",
                            "periodStartLabel":  "Cash, cash equivalents and restricted cash at beginning of period",
                            "totalLabel":  "Total cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r65",
                    "r392"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net (decrease) increase in cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]",
                            "terseLabel":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfWarrantOrRightAxis":  {
                "auth_ref":  [
                    "r253",
                    "r280"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of warrant or right issued.",
                            "label":  "Class of Warrant or Right [Axis]",
                            "terseLabel":  "Class of Warrant or Right [Axis]"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfWarrantOrRightDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the class or type of warrant or right outstanding.  Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame.  Warrants are often included in a new debt issue to entice investors by a higher return potential.  The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company.  Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
                            "label":  "Class of Warrant or Right [Domain]",
                            "terseLabel":  "Class of Warrant or Right [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1":  {
                "auth_ref":  [
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise price per share or per unit of warrants or rights outstanding.",
                            "label":  "Class of Warrant or Right, Exercise Price of Warrants or Rights",
                            "verboseLabel":  "Exercise Price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights":  {
                "auth_ref":  [
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of securities into which the class of warrant or right may be converted.  For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
                            "label":  "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
                            "verboseLabel":  "Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CollaborativeArrangementMember":  {
                "auth_ref":  [
                    "r350"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
                            "label":  "Collaborative Arrangement [Member]",
                            "terseLabel":  "Collaborative Arrangement"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
                            "terseLabel":  "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r30",
                    "r470",
                    "r487"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and contingencies (Note 9)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]",
                            "terseLabel":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r203",
                    "r204",
                    "r205",
                    "r208",
                    "r514"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "COMMITMENTS AND CONTINGENCIES"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIES"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r31"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Common Stock, Capital Shares Reserved for Future Issuance",
                            "terseLabel":  "Total number of common shares reserved for future issuance"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r82",
                    "r83",
                    "r370"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r16"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value per share (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r16"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, authorized (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r16"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, issued (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r16",
                    "r245"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "terseLabel":  "Common stock, outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r16",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "verboseLabel":  "Common stock ($0.01 par value per share); 60,000,000 shares authorized at September 30, 2022 and December 31, 2021; 4,933,288 and 4,881,851 shares issued and outstanding\u00a0at September 30, 2022 and December 31, 2021, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "auth_ref":  [
                    "r41",
                    "r43",
                    "r44",
                    "r52",
                    "r473",
                    "r489"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "totalLabel":  "Comprehensive loss"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for comprehensive income.",
                            "label":  "Comprehensive Income, Policy [Policy Text Block]",
                            "terseLabel":  "Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomePolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ComputerSoftwareIntangibleAssetMember":  {
                "auth_ref":  [
                    "r197",
                    "r198",
                    "r346"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
                            "label":  "Computer Software, Intangible Asset [Member]",
                            "terseLabel":  "Software"
                            }
                        }
                    },
                "localname":  "ComputerSoftwareIntangibleAssetMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "auth_ref":  [
                    "r118",
                    "r479"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for credit risk.",
                            "label":  "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
                            "terseLabel":  "Concentration of Credit Risk"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskCreditRisk",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConcentrationRiskLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Concentration Risk [Line Items]",
                            "terseLabel":  "Concentration of credit risk"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskTable":  {
                "auth_ref":  [
                    "r121",
                    "r122",
                    "r123",
                    "r124",
                    "r381",
                    "r382",
                    "r513"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
                            "label":  "Concentration Risk [Table]",
                            "terseLabel":  "Concentration Risk [Table]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r74",
                    "r355"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Consolidation, Policy [Policy Text Block]",
                            "terseLabel":  "Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CostsAndExpenses":  {
                "auth_ref":  [
                    "r54"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total costs of sales and operating expenses for the period.",
                            "label":  "Costs and Expenses",
                            "totalLabel":  "Total expenses"
                            }
                        }
                    },
                "localname":  "CostsAndExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostsAndExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Costs and Expenses [Abstract]",
                            "terseLabel":  "Expenses:"
                            }
                        }
                    },
                "localname":  "CostsAndExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtSecuritiesAvailableForSaleTable":  {
                "auth_ref":  [
                    "r175"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale [Table]",
                            "terseLabel":  "Debt Securities, Available-for-sale [Table]"
                            }
                        }
                    },
                "localname":  "DebtSecuritiesAvailableForSaleTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock":  {
                "auth_ref":  [
                    "r175"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
                            "label":  "Debt Securities, Available-for-Sale [Table Text Block]",
                            "terseLabel":  "Schedule of investment holdings"
                            }
                        }
                    },
                "localname":  "DebtSecuritiesAvailableForSaleTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r68",
                    "r79",
                    "r335",
                    "r342",
                    "r343",
                    "r344"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "terseLabel":  "Deferred income tax provision"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r68",
                    "r135"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation, Depletion and Amortization",
                            "terseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r281",
                    "r282",
                    "r315",
                    "r316",
                    "r318",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement [Text Block]",
                            "terseLabel":  "STOCK-BASED COMPENSATION"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATION"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement [Abstract]",
                            "terseLabel":  "Share-based Payment Arrangement [Abstract]"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share [Abstract]",
                            "terseLabel":  "Earnings Per Share [Abstract]"
                            }
                        }
                    },
                "localname":  "EarningsPerShareAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r53",
                    "r91",
                    "r92",
                    "r93",
                    "r94",
                    "r95",
                    "r100",
                    "r102",
                    "r104",
                    "r105",
                    "r106",
                    "r110",
                    "r111",
                    "r371",
                    "r372",
                    "r474",
                    "r490"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic",
                            "terseLabel":  "Basic net loss per share (in USD per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "auth_ref":  [
                    "r53",
                    "r91",
                    "r92",
                    "r93",
                    "r94",
                    "r95",
                    "r102",
                    "r104",
                    "r105",
                    "r106",
                    "r110",
                    "r111",
                    "r371",
                    "r372",
                    "r474",
                    "r490"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Diluted",
                            "terseLabel":  "Diluted net loss per share (in USD per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r107",
                    "r108",
                    "r109",
                    "r112"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for earnings per share.",
                            "label":  "Earnings Per Share [Text Block]",
                            "terseLabel":  "BASIC AND DILUTED NET LOSS PER SHARE"
                            }
                        }
                    },
                "localname":  "EarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARE"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r392"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies.  Excludes amounts for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
                            "terseLabel":  "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Employee-related Liabilities, Current",
                            "terseLabel":  "Employee compensation and benefits"
                            }
                        }
                    },
                "localname":  "EmployeeRelatedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r317"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
                            "terseLabel":  "Weighted average remaining recognition period (years)"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":  {
                "auth_ref":  [
                    "r317"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for option under share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Stock-based compensation expense, net of estimated forfeitures, related to unvested awards not yet recognized"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Share-Based Payment Arrangement, Option [Member]",
                            "terseLabel":  "Employee stock option",
                            "verboseLabel":  "Options"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tangible personal property used to produce goods and services.",
                            "label":  "Equipment [Member]",
                            "terseLabel":  "Equipment"
                            }
                        }
                    },
                "localname":  "EquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]",
                            "terseLabel":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r2",
                    "r46",
                    "r47",
                    "r48",
                    "r82",
                    "r83",
                    "r84",
                    "r87",
                    "r96",
                    "r98",
                    "r113",
                    "r184",
                    "r245",
                    "r252",
                    "r320",
                    "r321",
                    "r322",
                    "r339",
                    "r340",
                    "r370",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r398",
                    "r423",
                    "r500",
                    "r501",
                    "r502"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
                            "terseLabel":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable":  {
                "auth_ref":  [
                    "r374",
                    "r375",
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
                            "label":  "Fair Value, Recurring and Nonrecurring [Table]",
                            "terseLabel":  "Fair Value, Recurring and Nonrecurring [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r220",
                    "r223",
                    "r224",
                    "r269",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r375",
                    "r430",
                    "r431",
                    "r432"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value Hierarchy and NAV [Axis]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByMeasurementFrequencyAxis":  {
                "auth_ref":  [
                    "r374",
                    "r375",
                    "r376",
                    "r377",
                    "r380"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by measurement frequency.",
                            "label":  "Measurement Frequency [Axis]",
                            "terseLabel":  "Measurement Frequency [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByMeasurementFrequencyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Disclosures [Abstract]",
                            "terseLabel":  "Fair Value Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r378"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities.  Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
                            "label":  "Fair Value Disclosures [Text Block]",
                            "terseLabel":  "FAIR VALUE MEASUREMENTS"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTS"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "auth_ref":  [
                    "r220",
                    "r269",
                    "r270",
                    "r275",
                    "r276",
                    "r375",
                    "r430"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
                            "label":  "Fair Value, Inputs, Level 1 [Member]",
                            "terseLabel":  "Quoted prices in active markets\u00a0for identical assets (Level 1)"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel1Member",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel2Member":  {
                "auth_ref":  [
                    "r220",
                    "r223",
                    "r224",
                    "r269",
                    "r270",
                    "r275",
                    "r276",
                    "r375",
                    "r431"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
                            "label":  "Fair Value, Inputs, Level 2 [Member]",
                            "terseLabel":  "Significant\u00a0other observable\u00a0inputs (Level 2)"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel2Member",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel3Member":  {
                "auth_ref":  [
                    "r220",
                    "r223",
                    "r224",
                    "r269",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r375",
                    "r432"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Inputs, Level 3 [Member]",
                            "terseLabel":  "Significant unobservable inputs (Level 3)"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel3Member",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementFrequencyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement frequency.",
                            "label":  "Measurement Frequency [Domain]",
                            "terseLabel":  "Measurement Frequency [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementFrequencyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
                            "label":  "Fair Value Measurement, Policy [Policy Text Block]",
                            "terseLabel":  "Fair Value Measurements"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    "r220",
                    "r223",
                    "r224",
                    "r269",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r430",
                    "r431",
                    "r432"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
                            "label":  "Fair Value Hierarchy and NAV [Domain]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsRecurringMember":  {
                "auth_ref":  [
                    "r378",
                    "r380"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Frequent fair value measurement.  Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
                            "label":  "Fair Value, Recurring [Member]",
                            "terseLabel":  "Fair Value, Measurements, Recurring"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsRecurringMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FinancialInstrumentAxis":  {
                "auth_ref":  [
                    "r173",
                    "r174",
                    "r176",
                    "r177",
                    "r178",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r222",
                    "r243",
                    "r360",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r436",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r442",
                    "r443",
                    "r444",
                    "r445",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r532",
                    "r533",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r538"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of financial instrument.",
                            "label":  "Financial Instrument [Axis]",
                            "terseLabel":  "Financial Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "FinancialInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock":  {
                "auth_ref":  [
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
                            "label":  "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
                            "terseLabel":  "Foreign Currency Translation"
                            }
                        }
                    },
                "localname":  "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FurnitureAndFixturesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities.  Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
                            "label":  "Furniture and Fixtures [Member]",
                            "terseLabel":  "Furniture and fixtures"
                            }
                        }
                    },
                "localname":  "FurnitureAndFixturesMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GrantMember":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award of money not required to be repaid.",
                            "label":  "Grant [Member]",
                            "terseLabel":  "Grant"
                            }
                        }
                    },
                "localname":  "GrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock":  {
                "auth_ref":  [
                    "r199",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets.  An entity also may disclose its accounting policy for long-lived assets to be sold.  This policy excludes goodwill and intangible assets.",
                            "label":  "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
                            "terseLabel":  "Impairment of Long-Lived Assets"
                            }
                        }
                    },
                "localname":  "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r50",
                    "r137",
                    "r146",
                    "r149",
                    "r152",
                    "r155",
                    "r462",
                    "r471",
                    "r475",
                    "r492"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Loss from operations before income taxes"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]",
                            "terseLabel":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r80",
                    "r97",
                    "r98",
                    "r136",
                    "r331",
                    "r341",
                    "r345",
                    "r493"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "negatedTerseLabel":  "Income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r45",
                    "r329",
                    "r330",
                    "r332",
                    "r333",
                    "r334",
                    "r336"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerAsset":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
                            "label":  "Increase (Decrease) in Contract with Customer, Asset",
                            "negatedLabel":  "Unbilled receivables"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerAsset",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Changes in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedLabel":  "Prepaid expenses and other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                            "terseLabel":  "Increase (decrease) in stockholders' equity"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInStockholdersEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InvestmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r179",
                    "r491"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for investment in financial asset.",
                            "label":  "Investment, Policy [Policy Text Block]",
                            "terseLabel":  "Investments"
                            }
                        }
                    },
                "localname":  "InvestmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investments, Debt and Equity Securities [Abstract]",
                            "terseLabel":  "Investments, Debt and Equity Securities [Abstract]"
                            }
                        }
                    },
                "localname":  "InvestmentsDebtAndEquitySecuritiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r175",
                    "r463",
                    "r477",
                    "r511",
                    "r539"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for investments in certain debt and equity securities.",
                            "label":  "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
                            "terseLabel":  "INVESTMENTS"
                            }
                        }
                    },
                "localname":  "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTS"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeaseCost":  {
                "auth_ref":  [
                    "r414",
                    "r416"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lease cost recognized by lessee for lease contract.",
                            "label":  "Lease, Cost",
                            "totalLabel":  "Total lease cost, net"
                            }
                        }
                    },
                "localname":  "LeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseCostAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease, Cost [Abstract]",
                            "terseLabel":  "Lease cost:"
                            }
                        }
                    },
                "localname":  "LeaseCostAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "auth_ref":  [
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
                            "label":  "Lease, Cost [Table Text Block]",
                            "terseLabel":  "Lease costs and other information"
                            }
                        }
                    },
                "localname":  "LeaseCostTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeasesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases [Abstract]",
                            "terseLabel":  "Leases [Abstract]"
                            }
                        }
                    },
                "localname":  "LeasesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeLeasesPolicyTextBlock":  {
                "auth_ref":  [
                    "r408"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
                            "label":  "Lessee, Leases [Policy Text Block]",
                            "terseLabel":  "Right-of-Use Assets"
                            }
                        }
                    },
                "localname":  "LesseeLeasesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r415"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
                            "label":  "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
                            "terseLabel":  "Maturity analysis of lease liabilities"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid",
                            "terseLabel":  "Undiscounted future lease payments",
                            "totalLabel":  "Total undiscounted future lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails",
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year One",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Four",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Three",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Two",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r415"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
                            "terseLabel":  "2022 (October to December)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r415"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
                            "negatedTerseLabel":  "Amount of lease payments representing interest"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r417"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "Lessee, Operating Leases [Text Block]",
                            "terseLabel":  "LEASES"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASES"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LettersOfCreditOutstandingAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
                            "label":  "Letters of Credit Outstanding, Amount",
                            "terseLabel":  "Letter of credit"
                            }
                        }
                    },
                "localname":  "LettersOfCreditOutstandingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r27",
                    "r78",
                    "r148",
                    "r180",
                    "r209",
                    "r210",
                    "r211",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r354",
                    "r358",
                    "r359",
                    "r383",
                    "r424",
                    "r425"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r22",
                    "r78",
                    "r180",
                    "r383",
                    "r426",
                    "r466",
                    "r485"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities and stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "Liabilities and Stockholders\u2019 Equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r9",
                    "r29",
                    "r78",
                    "r180",
                    "r209",
                    "r210",
                    "r211",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r354",
                    "r358",
                    "r359",
                    "r383",
                    "r424",
                    "r425",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current Liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_MoneyMarketFundsMember":  {
                "auth_ref":  [
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
                            "label":  "Money Market Funds [Member]",
                            "terseLabel":  "Money market funds"
                            }
                        }
                    },
                "localname":  "MoneyMarketFundsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r65"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash (used in) provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Cash flows from financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r65"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash provided by investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
                            "terseLabel":  "Cash flows from investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r65",
                    "r66",
                    "r69"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
                            "terseLabel":  "Cash flows from operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r5",
                    "r39",
                    "r42",
                    "r48",
                    "r51",
                    "r69",
                    "r78",
                    "r86",
                    "r91",
                    "r92",
                    "r93",
                    "r94",
                    "r97",
                    "r98",
                    "r103",
                    "r137",
                    "r146",
                    "r149",
                    "r152",
                    "r155",
                    "r180",
                    "r209",
                    "r210",
                    "r211",
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r372",
                    "r383",
                    "r472",
                    "r488"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "netLabel":  "Net loss",
                            "terseLabel":  "Net loss",
                            "totalLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
                            "terseLabel":  "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable":  {
                "auth_ref":  [
                    "r0",
                    "r1",
                    "r2",
                    "r3",
                    "r4",
                    "r85",
                    "r86",
                    "r87",
                    "r88",
                    "r89",
                    "r90",
                    "r93",
                    "r99",
                    "r110",
                    "r166",
                    "r167",
                    "r181",
                    "r182",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r320",
                    "r321",
                    "r322",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r347",
                    "r348",
                    "r349",
                    "r362",
                    "r363",
                    "r364",
                    "r365",
                    "r366",
                    "r367",
                    "r368",
                    "r369",
                    "r370",
                    "r371",
                    "r372",
                    "r373",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r388",
                    "r389",
                    "r390",
                    "r391",
                    "r400",
                    "r401",
                    "r402",
                    "r403",
                    "r404",
                    "r405",
                    "r418",
                    "r419",
                    "r420",
                    "r421",
                    "r422",
                    "r423",
                    "r459",
                    "r460",
                    "r461",
                    "r498",
                    "r499",
                    "r500",
                    "r501",
                    "r502",
                    "r503",
                    "r504",
                    "r505",
                    "r506",
                    "r507",
                    "r508",
                    "r509"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
                            "label":  "Accounting Standards Update and Change in Accounting Principle [Table]",
                            "terseLabel":  "New Accounting Pronouncements or Change in Accounting Principle [Table]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recent Accounting Standards"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r57"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Nonoperating Income (Expense)",
                            "totalLabel":  "Total other income (expense)"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nonoperating Income (Expense) [Abstract]",
                            "terseLabel":  "Other income (expense):"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "auth_ref":  [
                    "r130"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
                            "label":  "Number of Operating Segments",
                            "terseLabel":  "Number of operating segments"
                            }
                        }
                    },
                "localname":  "NumberOfOperatingSegments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r137",
                    "r146",
                    "r149",
                    "r152",
                    "r155"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Loss from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseCost":  {
                "auth_ref":  [
                    "r409",
                    "r416"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
                            "label":  "Operating Lease, Cost",
                            "terseLabel":  "Operating lease cost"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r407"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Operating Lease, Liability",
                            "totalLabel":  "Total lease liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r407"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating Lease, Liability, Current",
                            "terseLabel":  "Current portion of lease liabilities",
                            "verboseLabel":  "Short-term lease liability"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r407"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Operating Lease, Liability, Noncurrent",
                            "terseLabel":  "Lease liabilities, net of current portion"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r406"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease.",
                            "label":  "Operating Lease, Right-of-Use Asset",
                            "terseLabel":  "Right-of-use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r413",
                    "r416"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time.",
                            "label":  "Operating Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Weighted-average discount rate"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r412",
                    "r416"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Weighted-average remaining lease term"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
                            "terseLabel":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Accrued Liabilities, Current",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r11"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCommitment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Minimum amount of other commitment not otherwise specified in the taxonomy.  Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
                            "label":  "Other Commitment",
                            "terseLabel":  "Other commitment"
                            }
                        }
                    },
                "localname":  "OtherCommitment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCommitmentsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of other commitment.",
                            "label":  "Other Commitments [Axis]",
                            "terseLabel":  "Other Commitments [Axis]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Other future obligation.",
                            "label":  "Other Commitments [Domain]",
                            "terseLabel":  "Other Commitments [Domain]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherCommitmentsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Other Commitments [Line Items]",
                            "terseLabel":  "Other Commitments [Line Items]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about obligations resulting from other commitments.",
                            "label":  "Other Commitments [Table]",
                            "terseLabel":  "Other Commitments [Table]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent":  {
                "auth_ref":  [
                    "r351",
                    "r352",
                    "r356"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
                            "label":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
                            "terseLabel":  "Change in foreign currency translation adjustment, net of income tax"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent":  {
                "auth_ref":  [
                    "r40",
                    "r43",
                    "r351",
                    "r352",
                    "r356"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
                            "label":  "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
                            "terseLabel":  "Effect of foreign currency translation and unrealized loss on investments",
                            "totalLabel":  "Total other comprehensive loss"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
                            "terseLabel":  "Other comprehensive loss"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax":  {
                "auth_ref":  [
                    "r34",
                    "r36"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).  Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
                            "label":  "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
                            "terseLabel":  "Change in unrealized loss on investments"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r58"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "terseLabel":  "Other income (expense), net"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]",
                            "terseLabel":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "localname":  "PayablesAndAccrualsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PaymentsOfStockIssuanceCosts":  {
                "auth_ref":  [
                    "r64"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for cost incurred directly with the issuance of an equity security.",
                            "label":  "Payments of Stock Issuance Costs",
                            "terseLabel":  "Issuance costs"
                            }
                        }
                    },
                "localname":  "PaymentsOfStockIssuanceCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    "r63"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Payment, Tax Withholding, Share-Based Payment Arrangement",
                            "negatedTerseLabel":  "Taxes paid on employees' behalf related to vesting of stock awards"
                            }
                        }
                    },
                "localname":  "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r60"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedLabel":  "Purchase of property and equipment"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireShortTermInvestments":  {
                "auth_ref":  [
                    "r61"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle.  Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
                            "label":  "Payments to Acquire Short-Term Investments",
                            "negatedLabel":  "Purchase of investments"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r15",
                    "r229"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Preferred stock, par value per share (in dollars per share)"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r15"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, authorized (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r15",
                    "r229"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued",
                            "terseLabel":  "Preferred stock, issued (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r15"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred Stock, Shares Outstanding",
                            "terseLabel":  "Preferred stock, outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r15",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "verboseLabel":  "Preferred stock ($0.01 par value per share); 5,000,000 shares authorized; no shares issued or outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r24"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "terseLabel":  "Prepaid expenses and other current assets"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrivatePlacementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
                            "label":  "Private Placement [Member]",
                            "verboseLabel":  "Private offering"
                            }
                        }
                    },
                "localname":  "PrivatePlacementMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfPrivatePlacement":  {
                "auth_ref":  [
                    "r62"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
                            "label":  "Proceeds from Issuance of Private Placement",
                            "terseLabel":  "Proceeds from public offering, net of issuance costs"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfPrivatePlacement",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleOfShortTermInvestments":  {
                "auth_ref":  [
                    "r59"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle.  Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
                            "label":  "Proceeds from Sale of Short-Term Investments",
                            "terseLabel":  "Proceeds from the maturity of short-term investments"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleOfShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromWarrantExercises":  {
                "auth_ref":  [
                    "r62"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from holders exercising their stock warrants.",
                            "label":  "Proceeds from Warrant Exercises",
                            "terseLabel":  "Proceeds from warrants exercised"
                            }
                        }
                    },
                "localname":  "ProceedsFromWarrantExercises",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r201"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]",
                            "terseLabel":  "Property, Plant and Equipment, Type [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r201",
                    "r426",
                    "r478",
                    "r486"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Property and equipment, net",
                            "verboseLabel":  "Identifiable long-lived assets"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r201",
                    "r515",
                    "r516"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "Property, Plant and Equipment, Policy [Policy Text Block]",
                            "terseLabel":  "Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r201"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "terseLabel":  "Estimated Useful Lives of Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r200"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Long-Lived Tangible Asset [Domain]",
                            "terseLabel":  "Property, Plant and Equipment, Type [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
                            "label":  "Property, Plant and Equipment, Useful Life",
                            "terseLabel":  "Estimated useful life"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "auth_ref":  [
                    "r328"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
                            "label":  "Research and Development Expense, Policy [Policy Text Block]",
                            "terseLabel":  "Research and Development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalents":  {
                "auth_ref":  [
                    "r10",
                    "r70",
                    "r72",
                    "r464",
                    "r482"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        },
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash and Cash Equivalents",
                            "terseLabel":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails",
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember":  {
                "auth_ref":  [
                    "r10"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of cash and cash equivalent.  Cash is currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash and Cash Equivalents [Domain]",
                            "terseLabel":  "Cash and Cash Equivalents [Domain]"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "Restricted Stock Awards"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r18",
                    "r252",
                    "r426",
                    "r484",
                    "r504",
                    "r509"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r2",
                    "r82",
                    "r83",
                    "r84",
                    "r87",
                    "r96",
                    "r98",
                    "r184",
                    "r320",
                    "r321",
                    "r322",
                    "r339",
                    "r340",
                    "r370",
                    "r500",
                    "r502"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r133",
                    "r134",
                    "r145",
                    "r150",
                    "r151",
                    "r157",
                    "r158",
                    "r161",
                    "r263",
                    "r264",
                    "r458"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "terseLabel":  "Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED",
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r75",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r268"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue from Contract with Customer [Policy Text Block]",
                            "terseLabel":  "Grant Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenuesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenues [Abstract]",
                            "terseLabel":  "Revenue:"
                            }
                        }
                    },
                "localname":  "RevenuesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Revenues from External Customers and Long-Lived Assets [Line Items]",
                            "terseLabel":  "Geographic Information"
                            }
                        }
                    },
                "localname":  "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs.",
                            "label":  "Sale of Stock, Consideration Received on Transaction",
                            "terseLabel":  "Gross proceeds"
                            }
                        }
                    },
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale of Stock [Domain]",
                            "terseLabel":  "Sale of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
                            "label":  "Sale of Stock, Number of Shares Issued in Transaction",
                            "verboseLabel":  "Common stock issued in offering (in shares)"
                            }
                        }
                    },
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of Stock, Price Per Share",
                            "terseLabel":  "Common stock price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accrued liabilities.",
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of accrued expenses"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r107"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
                            "terseLabel":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r107"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
                            "terseLabel":  "Schedule of number of shares of potentially dilutive common stock related to options and warrants that were excluded from the calculation of dilutive shares"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARETables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Securities, Available-for-Sale [Line Items]",
                            "terseLabel":  "Debt Securities, Available-for-sale [Line Items]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAvailableForSaleSecuritiesLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of cash and cash equivalents.",
                            "label":  "Schedule of Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Schedule of Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashAndCashEquivalentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable":  {
                "auth_ref":  [
                    "r350"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
                            "terseLabel":  "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock":  {
                "auth_ref":  [
                    "r374",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis.  The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
                            "label":  "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
                            "terseLabel":  "Assets and liabilities measured at fair value on a recurring basis"
                            }
                        }
                    },
                "localname":  "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r295"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
                            "label":  "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
                            "terseLabel":  "Schedule of restricted stock units activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock":  {
                "auth_ref":  [
                    "r72",
                    "r464",
                    "r482"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
                            "label":  "Restrictions on Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Schedule of Restricted Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock":  {
                "auth_ref":  [
                    "r55",
                    "r160"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
                            "label":  "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
                            "terseLabel":  "Schedule of the geographic distribution of revenues and long-lived assets"
                            }
                        }
                    },
                "localname":  "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable":  {
                "auth_ref":  [
                    "r49",
                    "r160"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
                            "label":  "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
                            "terseLabel":  "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r277",
                    "r279",
                    "r282",
                    "r283",
                    "r284",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r303",
                    "r304",
                    "r306",
                    "r307",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r314"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
                            "terseLabel":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r286",
                    "r302",
                    "r305"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
                            "terseLabel":  "Summary of option activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r13",
                    "r15",
                    "r16",
                    "r76",
                    "r114",
                    "r115",
                    "r225",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r232",
                    "r234",
                    "r238",
                    "r243",
                    "r245",
                    "r246",
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]",
                            "terseLabel":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockByClassTextBlock":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r16",
                    "r226",
                    "r227",
                    "r228",
                    "r246",
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.  If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
                            "label":  "Schedule of Stock by Class [Table Text Block]",
                            "terseLabel":  "Schedule of primary rights of convertible preferred stockholders, and common stock shares reserved for future issuance"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock":  {
                "auth_ref":  [
                    "r253",
                    "r280"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of warrants or rights issued.  Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame.  Warrants are often included in a new debt issue to entice investors by a higher return potential.  The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company.  Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.  Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
                            "label":  "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
                            "terseLabel":  "Information with regard to outstanding warrants to purchase common stock"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]",
                            "terseLabel":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r129",
                    "r131",
                    "r132",
                    "r137",
                    "r138",
                    "r149",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r160",
                    "r161",
                    "r162"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "Segment Reporting Disclosure [Text Block]",
                            "terseLabel":  "GEOGRAPHIC INFORMATION"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/GEOGRAPHICINFORMATION"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    "r139",
                    "r140",
                    "r141",
                    "r142",
                    "r143",
                    "r144",
                    "r158"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for segment reporting.",
                            "label":  "Segment Reporting, Policy [Policy Text Block]",
                            "terseLabel":  "Segment Information"
                            }
                        }
                    },
                "localname":  "SegmentReportingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r56"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling, General and Administrative Expense",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock":  {
                "auth_ref":  [
                    "r327"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
                            "label":  "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
                            "terseLabel":  "General and Administrative Expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
                            "terseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r299"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "verboseLabel":  "Awarded (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r296",
                    "r297"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "periodEndLabel":  "Outstanding (in shares)",
                            "periodStartLabel":  "Outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
                            "terseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms":  {
                "auth_ref":  [
                    "r306"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
                            "terseLabel":  "Weighted average remaining contractual life"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r300"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
                            "negatedTerseLabel":  "Released (in shares)",
                            "terseLabel":  "Shares vested in period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
                            "terseLabel":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of additional shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
                            "terseLabel":  "Number of additional shares authorized"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant":  {
                "auth_ref":  [
                    "r319"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
                            "terseLabel":  "Number of shares available for grant"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r289"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Options exercisable at the end of the period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r289"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "terseLabel":  "Options exercisable at the end of the period (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod":  {
                "auth_ref":  [
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
                            "negatedLabel":  "Expired (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "auth_ref":  [
                    "r293"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
                            "negatedTerseLabel":  "Forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    "r291"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Granted (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r287",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Outstanding at the end of the period (in shares)",
                            "periodStartLabel":  "Outstanding at the beginning of the period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
                            "terseLabel":  "Number\u00a0of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r287",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Outstanding at the end of the period (in dollars per share)",
                            "periodStartLabel":  "Outstanding at the beginning of the period (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
                            "terseLabel":  "Weighted\u00a0Average Exercise\u00a0Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r282",
                    "r283",
                    "r284",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r303",
                    "r304",
                    "r306",
                    "r307",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r314"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Award Type [Domain]",
                            "terseLabel":  "Award Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Exercised (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Expired (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r293"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Forfeited (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r291"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Granted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r285",
                    "r308",
                    "r309",
                    "r310",
                    "r311",
                    "r314",
                    "r323",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Share-Based Payment Arrangement [Policy Text Block]",
                            "terseLabel":  "Stock-based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Balance (in shares)",
                            "periodStartLabel":  "Balance (in shares)"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
                            "terseLabel":  "Shares withheld for employee taxes (in shares)"
                            }
                        }
                    },
                "localname":  "SharesPaidForTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermInvestments":  {
                "auth_ref":  [
                    "r23",
                    "r467",
                    "r468",
                    "r480"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
                            "label":  "Short-Term Investments",
                            "terseLabel":  "Short-term investments"
                            }
                        }
                    },
                "localname":  "ShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShortTermLeaseCost":  {
                "auth_ref":  [
                    "r410",
                    "r416"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
                            "label":  "Short-Term Lease, Cost",
                            "terseLabel":  "Short-term lease cost"
                            }
                        }
                    },
                "localname":  "ShortTermLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r73",
                    "r81"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "ACCOUNTING POLICIES"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIES"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r2",
                    "r33",
                    "r46",
                    "r47",
                    "r48",
                    "r82",
                    "r83",
                    "r84",
                    "r87",
                    "r96",
                    "r98",
                    "r113",
                    "r184",
                    "r245",
                    "r252",
                    "r320",
                    "r321",
                    "r322",
                    "r339",
                    "r340",
                    "r370",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r398",
                    "r423",
                    "r500",
                    "r501",
                    "r502"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]",
                            "terseLabel":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]",
                            "terseLabel":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Comprehensive Income [Abstract]",
                            "terseLabel":  "Statement of Comprehensive Income [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfIncomeAndComprehensiveIncomeAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]",
                            "terseLabel":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r82",
                    "r83",
                    "r84",
                    "r113",
                    "r458"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r32",
                    "r221",
                    "r245",
                    "r246",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period as a result of the conversion of convertible securities.",
                            "label":  "Stock Issued During Period, Shares, Conversion of Convertible Securities",
                            "terseLabel":  "Issuance of common stock for warrant exercises (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
                            "label":  "Stock Issued During Period, Shares, Employee Benefit Plan",
                            "terseLabel":  "Issuance of common stock for 401k match (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r15",
                    "r16",
                    "r245",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "terseLabel":  "Issuance of common stock in connection with stock offering, net of offering costs (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross":  {
                "auth_ref":  [
                    "r245",
                    "r252"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
                            "label":  "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
                            "terseLabel":  "Issuance of common stock for restricted stock units (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r15",
                    "r16",
                    "r245",
                    "r252",
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
                            "negatedTerseLabel":  "Exercised (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r33",
                    "r245",
                    "r252"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The gross value of stock issued during the period upon the conversion of convertible securities.",
                            "label":  "Stock Issued During Period, Value, Conversion of Convertible Securities",
                            "terseLabel":  "Issuance of common stock for warrant exercises"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
                            "label":  "Stock Issued During Period, Value, Employee Benefit Plan",
                            "terseLabel":  "Issuance of common stock for 401(k) match"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r15",
                    "r16",
                    "r245",
                    "r252"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Issuance of common stock in connection with stock offering, net of offering costs"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r16",
                    "r20",
                    "r21",
                    "r78",
                    "r165",
                    "r180",
                    "r383",
                    "r426"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Balance",
                            "periodStartLabel":  "Balance",
                            "totalLabel":  "Total stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity Attributable to Parent [Abstract]",
                            "terseLabel":  "Stockholders\u2019 Equity:"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r77",
                    "r230",
                    "r233",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r244",
                    "r252",
                    "r254",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "terseLabel":  "CAPITAL STOCK AND WARRANTS"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTS"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubleaseIncome":  {
                "auth_ref":  [
                    "r411",
                    "r416"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of sublease income excluding finance and operating lease expense.",
                            "label":  "Sublease Income",
                            "negatedTerseLabel":  "Sublease income"
                            }
                        }
                    },
                "localname":  "SubleaseIncome",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Sale of Stock [Axis]",
                            "terseLabel":  "Sale of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain":  {
                "auth_ref":  [
                    "r173",
                    "r174",
                    "r176",
                    "r177",
                    "r178",
                    "r222",
                    "r243",
                    "r360",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r436",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r442",
                    "r443",
                    "r444",
                    "r445",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r532",
                    "r533",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r538"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
                            "label":  "Financial Instruments [Domain]",
                            "terseLabel":  "Financial Instruments [Domain]"
                            }
                        }
                    },
                "localname":  "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TypeOfArrangementAxis":  {
                "auth_ref":  [
                    "r350"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
                            "terseLabel":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
                            }
                        }
                    },
                "localname":  "TypeOfArrangementAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember":  {
                "auth_ref":  [
                    "r476"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This category includes information about debt issued by US Government Corporations and Agencies.  Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
                            "label":  "US Government Corporations and Agencies Securities [Member]",
                            "terseLabel":  "U.S. government and agency securities"
                            }
                        }
                    },
                "localname":  "USGovernmentCorporationsAndAgenciesSecuritiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_USTreasuryAndGovernmentMember":  {
                "auth_ref":  [
                    "r269",
                    "r476",
                    "r510"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises.  Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
                            "label":  "US Treasury and Government [Member]",
                            "terseLabel":  "Government securities"
                            }
                        }
                    },
                "localname":  "USTreasuryAndGovernmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/INVESTMENTSDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnbilledContractsReceivable":  {
                "auth_ref":  [
                    "r457"
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party.  An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
                            "label":  "Unbilled Contracts Receivable",
                            "terseLabel":  "Unbilled receivables"
                            }
                        }
                    },
                "localname":  "UnbilledContractsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r116",
                    "r117",
                    "r119",
                    "r120",
                    "r125",
                    "r126",
                    "r127"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_WarrantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
                            "label":  "Warrant [Member]",
                            "terseLabel":  "Warrants"
                            }
                        }
                    },
                "localname":  "WarrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r101",
                    "r106"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Diluted (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
                            "terseLabel":  "Number of shares used in per share calculations:"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r100",
                    "r106"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Basic (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "yten_A410DowneyRoadAnd110GymnasiumPlaceMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "410 Downey Road And 110 Gymnasium Place [Member]",
                            "label":  "410 Downey Road And 110 Gymnasium Place [Member]",
                            "terseLabel":  "410 Downey Road and 110 Gymnasium Place"
                            }
                        }
                    },
                "localname":  "A410DowneyRoadAnd110GymnasiumPlaceMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_AccountsReceivableAfterAllowanceForCreditLossCurrentAndUnbilledContractsReceivable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accounts Receivable, After Allowance For Credit Loss, Current And Unbilled Contracts Receivable",
                            "label":  "Accounts Receivable, After Allowance For Credit Loss, Current And Unbilled Contracts Receivable",
                            "terseLabel":  "Accounts and unbilled receivables"
                            }
                        }
                    },
                "localname":  "AccountsReceivableAfterAllowanceForCreditLossCurrentAndUnbilledContractsReceivable",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_AccruedFieldTrialsAndRelatedExpensesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Field Trials And Related Expenses, Current",
                            "label":  "Accrued Field Trials And Related Expenses, Current",
                            "terseLabel":  "Field trials and related expenses"
                            }
                        }
                    },
                "localname":  "AccruedFieldTrialsAndRelatedExpensesCurrent",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_AccruedLeaseCost":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Lease Cost",
                            "label":  "Accrued Lease Cost",
                            "terseLabel":  "Leased facilities"
                            }
                        }
                    },
                "localname":  "AccruedLeaseCost",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_CJCheilJedangCorporationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "CJ CheilJedang Corporation [Member]",
                            "label":  "CJ CheilJedang Corporation [Member]",
                            "terseLabel":  "CJ CheilJedang Corporation"
                            }
                        }
                    },
                "localname":  "CJCheilJedangCorporationMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_ChargeForCompanyCommonStockMatch":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The noncash charge representing the fair value of Company common stock issued by the company to participants in the Company's 401(k) plan as a matching contribution during the reporting period.  As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.",
                            "label":  "Charge for Company Common Stock Match",
                            "terseLabel":  "Charge for 401(k)\u00a0company common stock match"
                            }
                        }
                    },
                "localname":  "ChargeForCompanyCommonStockMatch",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_ClassOfWarrantOrRightExercised":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class of Warrant Or Right, Exercised",
                            "label":  "Class of Warrant Or Right, Exercised",
                            "terseLabel":  "Warrants exercised (in shares)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExercised",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "yten_ClassOfWarrantOrRightExpired":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class of Warrant Or Right, Expired",
                            "label":  "Class of Warrant Or Right, Expired",
                            "terseLabel":  "Warrants expired (in shares)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExpired",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "yten_CollaborativeArrangementQuarterlyResearchFundingAndOptionFeesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative Arrangement, Quarterly Research Funding And Option Fees Payable",
                            "label":  "Collaborative Arrangement, Quarterly Research Funding And Option Fees Payable",
                            "terseLabel":  "Collaborative agreement, quarterly research funding and option fees payable"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementQuarterlyResearchFundingAndOptionFeesPayable",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_CollaborativeArrangementResearchFundingAndOptionFeesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative Arrangement, Research Funding And Option Fees Payable",
                            "label":  "Collaborative Arrangement, Research Funding And Option Fees Payable",
                            "terseLabel":  "Collaborative agreement, research funding and option fees payable"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementResearchFundingAndOptionFeesPayable",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_CollaborativeArrangementTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative Arrangement, Term",
                            "label":  "Collaborative Arrangement, Term",
                            "terseLabel":  "Collaborative agreement, term"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementTerm",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "yten_CollaborativeArrangementTermOfOptionForLicenseAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative Arrangement, Term Of Option For License Agreement",
                            "label":  "Collaborative Arrangement, Term Of Option For License Agreement",
                            "terseLabel":  "Collaborative agreement, term of option"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementTermOfOptionForLicenseAgreement",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "yten_CostOfRevenueResearchAndDevelopmentExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents the expenses associated with internal research and development as well as research and development services conducted for others are expensed as incurred.  Research and development expenses include direct costs for salaries, employee benefits, subcontractors; facility related expenses, depreciation and stock-based compensation related to employees and non-employees involved in the company's research and development, which also includes the costs related to revenue-producing contracts, which are recorded as research and development expenses, during the period by the entity.",
                            "label":  "Cost of Revenue Research and Development Expenses",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "CostOfRevenueResearchAndDevelopmentExpenses",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_EmployeeAndDirectorsStockOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "An arrangement whereby an employee or member of the Board of Directors is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.",
                            "label":  "Employee And Directors Stock Options [Member]",
                            "terseLabel":  "Options"
                            }
                        }
                    },
                "localname":  "EmployeeAndDirectorsStockOptionsMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_GainOnRelatedPartyInvestment":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gain On Related Party Investment",
                            "label":  "Gain On Related Party Investment",
                            "terseLabel":  "Gain on investment in related party"
                            }
                        }
                    },
                "localname":  "GainOnRelatedPartyInvestment",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_GrainProductionGuaranteedPaymentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Grain Production Guaranteed Payments",
                            "label":  "Grain Production Guaranteed Payments [Member]",
                            "terseLabel":  "Grain production guaranteed payments"
                            }
                        }
                    },
                "localname":  "GrainProductionGuaranteedPaymentsMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_IncreaseDecreaseInLeaseLiabilities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase (Decrease) In Lease Liabilities",
                            "label":  "Increase (Decrease) In Lease Liabilities",
                            "terseLabel":  "Lease liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInLeaseLiabilities",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_IntellectualPropertyCostsPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for intellectual property costs.",
                            "label":  "Intellectual Property Costs Policy [Text Block]",
                            "terseLabel":  "Intellectual Property Costs"
                            }
                        }
                    },
                "localname":  "IntellectualPropertyCostsPolicyTextBlock",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "yten_LeaseOtherInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lease, Other Information [Abstract]",
                            "label":  "Lease, Other Information [Abstract]",
                            "terseLabel":  "Other information as of:"
                            }
                        }
                    },
                "localname":  "LeaseOtherInformationAbstract",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "yten_LesseeOperatingSubleaseSubleasedArea":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Sublease, Subleased Area",
                            "label":  "Lessee, Operating Sublease, Subleased Area",
                            "terseLabel":  "Subleased area (in sq ft)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingSubleaseSubleasedArea",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "areaItemType"
                },
            "yten_LicensingAgreementsTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Licensing Agreements",
                            "label":  "Licensing Agreements [Text Block]",
                            "terseLabel":  "LICENSE AGREEMENTS"
                            }
                        }
                    },
                "localname":  "LicensingAgreementsTextBlock",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LICENSEAGREEMENTS"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "yten_MichiganStateUniversityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Michigan State University [Member]",
                            "label":  "Michigan State University [Member]",
                            "terseLabel":  "Michigan State University"
                            }
                        }
                    },
                "localname":  "MichiganStateUniversityMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_NoncashLeaseExpenseIncome":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncash Lease Expense (Income)",
                            "label":  "Noncash Lease Expense (Income)",
                            "terseLabel":  "Non-cash lease expense"
                            }
                        }
                    },
                "localname":  "NoncashLeaseExpenseIncome",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating Lease Liability, Noncurrent, Excluding Lease Included on Balance Sheet",
                            "label":  "Operating Lease Liability, Noncurrent, Excluding Lease Included on Balance Sheet",
                            "verboseLabel":  "Long-term lease liability"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payment Tax Withholding, Share Based Payment Arrangement, Excluding Employer Amount",
                            "label":  "Payment Tax Withholding, Share Based Payment Arrangement, Excluding Employer Amount",
                            "terseLabel":  "Taxes paid on employees' behalf related to vesting of stock awards"
                            }
                        }
                    },
                "localname":  "PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_PresidentialWayWoburnMassachusettsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Presidential Way, Woburn, Massachusetts [Member]",
                            "label":  "Presidential Way, Woburn, Massachusetts [Member]",
                            "terseLabel":  "19 Presidential Way"
                            }
                        }
                    },
                "localname":  "PresidentialWayWoburnMassachusettsMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/LEASESNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_ProceedsFromWarrantExercisesNet":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds From Warrant Exercises, Net",
                            "label":  "Proceeds From Warrant Exercises, Net",
                            "terseLabel":  "Proceeds from warrants exercised"
                            }
                        }
                    },
                "localname":  "ProceedsFromWarrantExercisesNet",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "yten_PublicOfferingMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Public Offering [Member]",
                            "label":  "Public Offering [Member]",
                            "terseLabel":  "Public offering"
                            }
                        }
                    },
                "localname":  "PublicOfferingMember",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails",
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_SeriesAWarrantExpiringDecember2022Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series A Warrant Expiring December 2022 [Member]",
                            "label":  "Series A Warrant Expiring December 2022 [Member]",
                            "terseLabel":  "Series A Warrants - expiration December 2022"
                            }
                        }
                    },
                "localname":  "SeriesAWarrantExpiringDecember2022Member",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_SeriesBWarrantExpiringMay2027Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series B Warrant Expiring May 2027 [Member]",
                            "label":  "Series B Warrant Expiring May 2027 [Member]",
                            "terseLabel":  "Series B Warrants - expiration May 2027"
                            }
                        }
                    },
                "localname":  "SeriesBWarrantExpiringMay2027Member",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percent",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percent",
                            "terseLabel":  "Additional shares authorized percentage"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "yten_WarrantExpiringJanuary2024Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrant Expiring January 2024 [Member]",
                            "label":  "Warrant Expiring January 2024 [Member]",
                            "terseLabel":  "Warrants - expiration January 2024"
                            }
                        }
                    },
                "localname":  "WarrantExpiringJanuary2024Member",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "yten_WarrantExpiringSeptember2024Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrant Expiring September 2024 [Member]",
                            "label":  "Warrant Expiring September 2024 [Member]",
                            "terseLabel":  "Warrants - expiration September 2024"
                            }
                        }
                    },
                "localname":  "WarrantExpiringSeptember2024Member",
                "nsuri":  "http://www.yield10bio.com/20220930",
                "presentation":  [
                    "http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails"
                    ],
                "xbrltype":  "domainItemType"
                }
            },
        "unitCount":  6
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/topic&trid=2144383"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/topic&trid=2134479"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/topic&trid=2134510"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(aa)",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/topic&trid=2196928"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(3)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(4)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(4))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.CC)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/topic&trid=2144648"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/topic&trid=2127136"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "50",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/topic&trid=2208762"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/topic&trid=49130388"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(A)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(B)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(C)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(03)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(v)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(l)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-30)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/topic&trid=2228938"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "35",
        "Subparagraph":  "(a)",
        "Topic":  "720",
        "URI":  "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.1)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "38",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(3)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c),(3)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)(1)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)(2)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)(1)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)(2)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(2)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(1)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/topic&trid=2175825"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "832",
        "URI":  "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "832",
        "URI":  "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(4)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/subtopic&trid=77888251"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(01)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(i)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(ii)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)(i)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(5)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(6)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(7)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(b)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "310",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r459":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "926",
        "URI":  "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r460":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "926",
        "URI":  "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r461":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "926",
        "URI":  "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r462":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
        },
    "r463":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "320",
        "Topic":  "940",
        "URI":  "https://asc.fasb.org/subtopic&trid=2176304"
        },
    "r464":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r465":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r466":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r467":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(4))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r468":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(5))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r469":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(6))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r470":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r471":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r472":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r473":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(26))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r474":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r475":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r476":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "320",
        "Subparagraph":  "(b)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
        },
    "r477":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "320",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/subtopic&trid=2209399"
        },
    "r478":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
        },
    "r479":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r480":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(1)(g))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r481":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r482":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(2))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r483":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(3))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r484":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r485":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r486":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r487":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r488":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r489":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(22))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(1))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r490":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r491":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(3)(b))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r492":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r493":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r494":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4H",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
        },
    "r495":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r496":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r497":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r498":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r499":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r500":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r501":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r502":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r503":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r504":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r505":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(ii)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r506":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iii)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r507":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iv)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r508":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r509":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r510":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
        },
    "r511":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "320",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/subtopic&trid=2324412"
        },
    "r512":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "310",
        "Subparagraph":  "(SX 210.12-29(Footnote 4))",
        "Topic":  "948",
        "URI":  "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
        },
    "r513":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
        },
    "r514":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
        },
    "r515":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Subparagraph":  "(d)",
        "Topic":  "958",
        "URI":  "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
        },
    "r516":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
        },
    "r517":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column B))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r518":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column C))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r519":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column D))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(24))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r520":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column E))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r521":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column F))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r522":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column G))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r523":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column H))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r524":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Column I))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r525":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Footnote 2))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r526":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Footnote 5))",
        "Topic":  "970",
        "URI":  "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r527":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r528":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r529":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r530":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r531":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r532":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402"
        },
    "r533":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(1)"
        },
    "r534":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)"
        },
    "r535":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(3)"
        },
    "r536":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(i)"
        },
    "r537":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(ii)"
        },
    "r538":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(iii)"
        },
    "r539":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1403"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r540":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.1)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/topic&trid=2122149"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(1)(Note 1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/topic&trid=2122369"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(4)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.M.Q2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
        }
    },
"version":  "2.1"
}


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/24/23  YIELD10 Bioscience, Inc.          424B5                  1:587K


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  YIELD10 Bioscience, Inc.          10-Q        3/31/22   59:4.5M
 3/25/22  YIELD10 Bioscience, Inc.          10-K       12/31/21   83:9.4M
Top
Filing Submission 0001121702-22-000049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 7:32:04.4am ET